Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
Press release – No. 19 / 2025 Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health Zealand Pharma targets five launches, +10 clinical pipeline programs, and…
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Press release – No. 18 / 2025 Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases Collaboration will combine Zealand Pharma's expertise in…
Delhi HC Allows Sun Pharma To Export Weight-Loss Drugs
The Delhi high court on Wednesday allowed Sun Pharma to manufacture and export its semaglutide-based weight-loss drugs, but restricted its sale in India till Novo Nordisk's secondary patent expires in March 2026. Sun Pharma has been allowed to…
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Pharma Equity Group A/S ('PEG') today announces that the company has signed a Letter of Intent regarding the…
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /CNW/ -- Innocan Pharma Corporation ('Innocan' or the 'Company') (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed…
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence
Healthcare stocks have lagged the broader market for the past three years, weighed down by post-COVID earnings volatility, policy uncertainties around drug pricing, and a surge in tech-driven gains from the AI boom. The sector's relative earnings…
BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $148,520.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of BridgeBio Pharma stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $74.26, for a total value of $148,520.00.
Menora Mivtachim Holdings LTD. Reduces Holdings in Urogen Pharma $URGN
Menora Mivtachim Holdings LTD. reduced its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 50.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,152,531 shares of the company's stock after…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s share price gapped down prior to trading on Wednesday. The stock had previously closed at $31.31, but opened at $29.80. Ascentage Pharma Group International…
Stempoint Capital LP Reduces Stock Holdings in BridgeBio Pharma, Inc. $BBIO
Stempoint Capital LP cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 73.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,630…
Stempoint Capital LP Boosts Stake in NewAmsterdam Pharma Company N.V. $NAMS
Stempoint Capital LP lifted its position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 46.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm…
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry's broadest in vitro diagnostic menu
With this approval, Roche's automated mass spectrometry platform now offers the industry's broadest in vitro diagnostic menu with 39 tests, including tests for therapeutic drug monitoring for immunosuppressants and antibiotics, as well as steroid…
OpenAI exec identifies 3 jobs that are not AI proof
Three industries are going to look very different in the next few years, according to an OpenAI executive. On an episode of the 'Unsupervised Learning' podcast, Olivier Godement, the head of product for business products at the ChatGPT maker…
Australia starting to build the safer internet big tech feared
Gift 5 articles to anyone you choose each month when you subscribe. Subscribe now Already a subscriber? The art of distraction is something global tech companies, or “big tech” colloquially, have mastered. In today's constant churn of…
Drug rebate rate cut by over a third after zero-tariff deal with US
Sign up for our email featuring expert insight and funding opportunities for entrepreneurs and SMEs I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. Rebates paid by drugs firms to the NHS…
Receive a Daily briefing on Pharma Industry News
Get Started